Consensus Abbott Laboratories

Equities

ABT

US0028241000

Market Closed - Nyse 04:00:02 2024-03-04 pm EST 5-day change 1st Jan Change
120 USD +1.20% Intraday chart for Abbott Laboratories +1.14% +9.06%

Evolution of the average Target Price on Abbott Laboratories

Price target over the last 5 years

History of analyst recommendation changes

535.olJcg-7PoefKH_fMWgLh-UdH5vqhL41mAnFXd5owpUs.mwIIs7md05a7WKe7Fm2jng0YvLTWd8oQTCItI-9G9T2TJTG6hPeWiI5LlA~2155e5316ad86467a18332f0cc2c14c1
Barclays Raises Abbott Laboratories' Price Target to $141 From $133, Keeps Overweight Rating MT
Raymond James Adjusts Price Target on Abbott Laboratories to $127 From $124, Maintains Outperform Rating MT
Citigroup Raises Abbott Laboratories Price Target to $126 From $123, Maintains Buy Rating MT
Bernstein Raises Abbott Laboratories Price Target to $133 From $125, Maintains Outperform Rating MT
JPMorgan Raises Abbott Laboratories Price Target to $125 From $122, Maintains Overweight Rating MT
UBS Raises Abbott Laboratories Price Target to $136 From $122, Maintains Buy Rating MT
Wall St Week Ahead-Maligned US real estate sector draws buyers eyeing rate cuts RE
Wall St Week Ahead-Maligned US real estate sector draws buyers eyeing rate cuts RE
RBC Adjusts Abbott Laboratories' Price Target to $128 From $119, Keeps Outperform Rating MT
Raymond James Raises Abbott Laboratories' Price Target to $124 From $110, Maintains Outperform Rating MT
Wells Fargo Raises Price Target on Abbott Laboratories to $121 From $116, Maintains Overweight Rating MT
UBS Raises Abbott Laboratories Price Target to $122 From $118, Maintains Buy Rating MT
Wells Fargo Cuts Price Target on Abbott Laboratories to $116 From $136, Maintains Overweight Rating MT
Morningstar Upgrades Abbott Laboratories to Buy From Hold, $104 Price Target MT
Raymond James Adjusts Abbott Laboratories Price Target to $110 From $123, Maintains Outperform Rating MT
Evercore ISI Adjusts Abbott Laboratories Price Target to $106 From $110, Maintains Outperform Rating MT
Morgan Stanley Adjusts Abbott Laboratories Price Target to $107 From $112, Maintains Equal Weight Rating MT
Bernstein Adjusts Abbott Laboratories Price Target to $122 From $133, Maintains Outperform Rating MT
Stifel Nicolaus Adjusts Abbott Laboratories Price Target to $115 From $125, Maintains Buy Rating MT
ANALYST RECOMMENDATIONS : Best Buy, Easyjet, Fortinet, Tesla, Netflix... Our Logo
ABB posts Q3 earnings in line with analyst expectations RE
UBS Cuts Price Target on Abbott Laboratories to $118 From $130, Keeps Buy Rating MT
Out with the old Our Logo
ANALYST RECOMMENDATIONS : Amgen, Best Buy, Comcast, Fedex, Mosaic... Our Logo
Barclays Adjusts Abbott Laboratories' Price Target to $132 From $127, Keeps Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
118.6 USD
Average target price
124.9 USD
Spread / Average Target
+5.31%
High Price Target
141 USD
Spread / Highest target
+18.87%
Low Price Target
104 USD
Spread / Lowest Target
-12.33%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Abbott Laboratories

Barclays
Raymond James
Citigroup
Bernstein
JPMorgan Chase
UBS
RBC Capital Markets
Wells Fargo Securities
Morgan Stanley
Stifel Nicolaus
Evercore ISI
Morningstar
Wolfe Research
Mizuho Securities
BTIG
Jefferies & Co.
Goldman Sachs
BofA Securities
Atlantic Equities
SVB Leerink
Redburn
Cowen
Credit Suisse
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW